Inflammation helps resolve pain
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

Access through your institution Buy or subscribe _Science Transl. Med_. https://doi.org/10.1126/scitranslmed.abj9954 (2022) Lower back pain often develops into a chronic condition. The
mechanism that underlies this transition is incompletely understood, but it is thought to involve activation of immune cells. To investigate this mechanism, the authors of a study published
in _Science Translational Medicine_ examined peripheral blood immune cells from 98 patients with lower back pain in the acute stage and again three months later, by which time the pain had
resolved in 49 patients and had become persistent in the other 49 patients. Transcriptomics data indicated that in the acute stage, expression of biological pathways related to inflammatory
responses was higher in patients whose pain later resolved than in those in whom it did not. Three months later, the ‘resolved’ group had 1,700 differentially expressed genes, a decrease in
the proportion of neutrophils, and downregulation of inflammatory response pathways compared with the acute stage, whereas the ‘persistent’ group showed no significant changes over time. The
authors replicated these findings in patients with a different musculoskeletal pain condition. In mouse models of inflammatory pain, dexamethasone or a nonsteroidal anti-inflammatory drug
(NSAID) reduced allodynia acutely but prolonged the duration of the pain episode. Depletion of neutrophils had the same effect, whereas an increase in neutrophils or the neutrophil-released
proteins S1000A8 or S1000A9 prevented the dexamethasone-induced prolongation of allodynia. In addition, data from the UK Biobank indicated that in people with acute back pain, self-reported
use of NSAIDs — but not any other analgesic medication — increased the risk of developing chronic pain. Together, these findings suggest that enhanced inflammatory responses in the acute
pain stage may protect against pain becoming chronic and raise the intriguing possibility that use of anti-inflammatory drugs for acute lower back pain may be counterproductive. This is a
preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value
online-access subscription $29.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more
Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS:
* Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Nature Neuroscience https://www.nature.com/neuro
Leonie Welberg Authors * Leonie Welberg View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Leonie Welberg. RIGHTS AND
PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Welberg, L. Inflammation helps resolve pain. _Nat Neurosci_ 25, 677 (2022).
https://doi.org/10.1038/s41593-022-01100-x Download citation * Published: 07 June 2022 * Issue Date: June 2022 * DOI: https://doi.org/10.1038/s41593-022-01100-x SHARE THIS ARTICLE Anyone you
share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the
Springer Nature SharedIt content-sharing initiative